Keyphrases
Inducer
100%
Antiviral Immune Response
100%
Protein mutants
100%
NS4B Inhibitors
100%
Zika Virus
100%
NS4B
57%
Live Attenuated Vaccine
21%
Flavivirus
14%
Virus Challenge
14%
3′-untranslated Region (3′-UTR)
14%
T Cells
7%
Site-directed mutagenesis
7%
Cell Response
7%
Immunogenicity
7%
Vaccination
7%
Mouse Model
7%
Type I Interferon
7%
In(III)
7%
Immunodeficient Mice
7%
Interleukin-6
7%
Virus Strains
7%
Attenuated Phenotype
7%
Host Innate Immunity
7%
CD4+
7%
Virus-specific
7%
Hydrophobic Region
7%
Titer
7%
CD8+ T
7%
Nucleotide Deletion
7%
Attenuating mutations
7%
Full Protection
7%
Immune Serum
7%
Virus Replication Complex
7%
Zika Virus Infection
7%
Passive Immunization
7%
Active Immunization
7%
Strong Types
7%
Neutralization Antibody
7%
Immune Active
7%
Pharmacology, Toxicology and Pharmaceutical Science
Antivirus Agent
100%
Mutant Protein
100%
Zika Virus
100%
Nonstructural Protein 4B
100%
Live Vaccine
20%
Flavivirus
13%
Disease
6%
Immunogenicity
6%
Mouse Model
6%
Virus Infection
6%
Interleukin 6
6%
Neutralizing Antibody
6%
Virus Strain
6%
Interferon
6%
Site-Directed Mutagenesis
6%
Antiserum
6%
CD8 Antigen
6%
Immunology and Microbiology
Antiviral Immune Response
100%
NS4B
100%
Zika Virus
100%
Attenuated Vaccine
20%
Live Vaccine
20%
Flavivirus
13%
T Cell
6%
Site Directed Mutagenesis
6%
Innate Immune System
6%
CD4
6%
Immunogenicity
6%
Wild Type
6%
Mouse Model
6%
interferon
6%
Viral Replication
6%
Titer
6%
Virus Strain
6%
Cytotoxic T-Cell
6%
Amino Terminal Sequence
6%
Neutralizing Antibody
6%
Interleukin 6
6%
Antiserum
6%
Active Immunization
6%